Wall Street analysts expect Owens & Minor, Inc. (NYSE:OMI) to announce earnings per share (EPS) of $0.01 for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Owens & Minor’s earnings, with the lowest EPS estimate coming in at $0.00 and the highest estimate coming in at $0.02. Owens & Minor reported earnings per share of $0.10 during the same quarter last year, which suggests a negative year-over-year growth rate of 90%. The business is expected to issue its next quarterly earnings results on Wednesday, August 5th.

According to Zacks, analysts expect that Owens & Minor will report full-year earnings of $0.52 per share for the current fiscal year, with EPS estimates ranging from $0.50 to $0.54. For the next fiscal year, analysts forecast that the firm will report earnings of $0.67 per share, with EPS estimates ranging from $0.61 to $0.75. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Owens & Minor.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.04. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.08 billion. Owens & Minor had a negative net margin of 0.65% and a positive return on equity of 7.44%. The business’s quarterly revenue was down 9.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.02 EPS.

A number of analysts have recently issued reports on OMI shares. Robert W. Baird downgraded shares of Owens & Minor from an “outperform” rating to a “neutral” rating and set a $8.00 price target on the stock. in a report on Tuesday, May 5th. Zacks Investment Research downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Friday, June 19th. ValuEngine downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a report on Sunday, June 14th. Cfra raised their price objective on shares of Owens & Minor from $8.50 to $9.50 and gave the stock a “buy” rating in a report on Wednesday, June 10th. Finally, Credit Suisse Group initiated coverage on shares of Owens & Minor in a report on Wednesday, April 22nd. They issued a “neutral” rating and a $8.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $8.30.

Shares of NYSE OMI traded up $0.02 during trading on Tuesday, reaching $7.62. 759,708 shares of the company traded hands, compared to its average volume of 2,390,647. The firm has a 50 day simple moving average of $7.45 and a 200-day simple moving average of $6.47. The company has a quick ratio of 0.91, a current ratio of 1.63 and a debt-to-equity ratio of 3.83. The stock has a market capitalization of $478.88 million, a PE ratio of -7.62, a P/E/G ratio of 1.67 and a beta of 0.13. Owens & Minor has a 52-week low of $2.43 and a 52-week high of $9.69.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be issued a $0.0025 dividend. This is an increase from Owens & Minor’s previous quarterly dividend of $0.00. The ex-dividend date of this dividend is Friday, June 12th. This represents a $0.01 dividend on an annualized basis and a dividend yield of 0.13%. Owens & Minor’s dividend payout ratio (DPR) is presently 1.79%.

In other news, Director Robert J. Henkel bought 10,000 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were bought at an average price of $7.29 per share, for a total transaction of $72,900.00. Following the purchase, the director now owns 10,000 shares in the company, valued at $72,900. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.15% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ensign Peak Advisors Inc bought a new stake in Owens & Minor during the 1st quarter worth approximately $29,000. Point72 Hong Kong Ltd bought a new stake in Owens & Minor during the 4th quarter worth approximately $40,000. Meeder Asset Management Inc. raised its stake in Owens & Minor by 324.4% during the 1st quarter. Meeder Asset Management Inc. now owns 5,088 shares of the company’s stock worth $46,000 after acquiring an additional 3,889 shares during the period. ProShare Advisors LLC bought a new stake in Owens & Minor during the 4th quarter worth approximately $53,000. Finally, First Trust Advisors LP bought a new stake in shares of Owens & Minor during the first quarter valued at approximately $56,000. Institutional investors own 87.50% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Further Reading: How Buying a Call Option Works

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.